-

Roni Aquires Veronica Enterprises, Expands Product Lines

COLUMBIA, S.C.--(BUSINESS WIRE)--Roni International, LLC is pleased to announce an exciting new investment, the acquisition of Veronica Enterprises, a California-based medical device manufacturer that will add to their already extensive portfolio of products for brain and nervous system monitoring.

As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Roni has been quickly growing, even during an otherwise challenging year. Veronica Enterprises provided another growth opportunity with a close alignment of culture, values, and product manufacturing expertise. The acquisition was completed on December 11, 2020.

“Veronica is a good fit for our first acquisition both because of their experience in our industry and the way our cultures and missions align,” said Shawn Regan, CEO and Co-Founder of Roni. “Even with minimal changes we believe within the first year we’ll be able to take the Veronica line of products and apply our manufacturing and sales best practices to see extensive growth.”

Veronica Enterprises has been manufacturing electrodes for neurodiagnostics, specializing in EMG electrodes, for over 50 years. For the last 30 years Veronica has been run by the father and son team of Bill and James ken, who have seen the industry evolve from reusable to disposable products, product innovations, and a host of market and regulatory changes that have defined neurodiagnostic medical devices. Their reputation in the EMG market especially made them an appealing partner for Roni.

“Veronica’s extensive experience is a good match for our innovation and steady growth,” said Dani. “Taking on their EMG products and legacy knowledge of EEG is a natural fit for our existing product lines and helps us encompass the full need of products that connect patients to machines.”

With the acquisition of Veronica, Roni International will now offer products for epilepsy monitoring, electroencephalography, electromyography, evoked potentials, polysomnography, intraoperative monitoring and more, better serving the needs of neurologists and critical care providers through one company.

Dani concluded, “The culture we have built at Roni and our reputation in the marketplace are incredibly important to us, and Veronica comes to us with more similarities than differences. We wanted growth that would ensure this dynamic would stay intact, and we’re excited about the future of these products and our company.”

About Roni

Roni International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Roni designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Roni enhances patient care worldwide by transforming medical device technology that links patients to equipment. Roni also offers custom packaging, custom products, private labeling and contract manufacturing services.

Contacts

Dani Brown
866.633.3754 [803.252.1222] office
803.252.1111 [fax]

BUSINESS WIRE, DALLAS (TEST)

NYSE MKT:TES
Details
Headquarters: Test, Test
CEO: Testing Testing
Employees: 2
Organization: PUB
Revenues: --- (2016)
Net Income: --- (2016)

Release Versions

Contacts

Dani Brown
866.633.3754 [803.252.1222] office
803.252.1111 [fax]

More News From BUSINESS WIRE, DALLAS (TEST)

UK REG TESTING UK Regulatory Announcement: Form 8.3 - Instem

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: UK REG TEST Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries mus...

UK REG TEST UK Regulatory Announcement: Form 8.3 - Gresham House

LONDON--(BUSINESS WIRE)--  Form 8.3 May 2018 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: UK REG TEST Asset Management PLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and b...

UK REG TESTING UK Regulatory Announcement: 2023 Exploration Season Commences at the Lolworth Range Project, Queensland

LONDON--(BUSINESS WIRE)--  RNS REACH UK REG TESTING plc (“UK REG TESTING”, “TEST” or the “Company”) 2023 Exploration Season Commences at the Lolworth Range Project, Queensland UK REG TESTING plc (LON: XXX), the exploration and development company focused on gold in Australia, is pleased to announce that exploration has begun for the 2023 field season at the Lolworth Range project, North Queensland, Australia, with follow-up exploration of identified Gold and Niobium-Tantalum targets already und...
Back to Newsroom